- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1109EUR$1,250USD£958GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1109EUR$1,250USD£958GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1109EUR$1,250USD£958GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1109EUR$1,250USD£958GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1109EUR$1,250USD£958GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1109EUR$1,250USD£958GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1109EUR$1,250USD£958GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1109EUR$1,250USD£958GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1109EUR$1,250USD£958GBP
- Report
- December 2024
- 30 Pages
Global
From €2884EUR$3,250USD£2,492GBP
- Report
- March 2025
- 145 Pages
Global
From €2662EUR$2,999USD£2,300GBP
- Report
- September 2024
- 135 Pages
Global
From €2662EUR$2,999USD£2,300GBP
- Report
- August 2025
- 381 Pages
Global
From €5192EUR$5,850USD£4,486GBP
- Report
- August 2025
- 272 Pages
Global
From €5192EUR$5,850USD£4,486GBP
- Report
- August 2025
- 193 Pages
Global
From €5192EUR$5,850USD£4,486GBP
- Report
- August 2025
- 131 Pages
Global
From €5192EUR$5,850USD£4,486GBP
- Report
- August 2025
- 276 Pages
Global
From €5192EUR$5,850USD£4,486GBP
- Report
- August 2025
- 258 Pages
Global
From €5192EUR$5,850USD£4,486GBP
- Report
- January 2025
- 185 Pages
Global
From €3994EUR$4,500USD£3,451GBP
- Report
- October 2024
- 200 Pages
Global
From €3328EUR$3,750USD£2,875GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more